2017
DOI: 10.1016/j.biopha.2017.09.069
|View full text |Cite
|
Sign up to set email alerts
|

Anti-hepatocarcinoma effect of cordycepin against NDEA-induced hepatocellular carcinomas via the PI3K/Akt/mTOR and Nrf2/HO-1/NF-κB pathway in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(21 citation statements)
references
References 33 publications
1
20
0
Order By: Relevance
“…Further, co-exposure to AFB 1 and FB 1 increase carcinogenicity via upregulation of IL-10, IL-4, lipid peroxidation (LP), and caspase 3 ( Abbes et al, 2016 ). Anti-carcinogenic compounds, such as cordycepin, a component of a rare caterpillar fungus, demonstrated protective effects in NDEA-induced HCC via downregulation of pro-inflammatory cytokines IL-6, IL−1β, IL-2, TNF-α and modulation of the PI3K-Akt-mTOR pathway ( Keshari et al, 2017 ; Zeng et al, 2017 ). In an AOM/DSS model of colon carcinogenesis, an anti-cancer compound celastrol, reduces COX-2, TNF-α, IL-6, IL−1β and iNOS ( Barker et al, 2018 ).…”
Section: Mechanisms Of Pro-tumorigenic Activity By Carcinogensmentioning
confidence: 99%
“…Further, co-exposure to AFB 1 and FB 1 increase carcinogenicity via upregulation of IL-10, IL-4, lipid peroxidation (LP), and caspase 3 ( Abbes et al, 2016 ). Anti-carcinogenic compounds, such as cordycepin, a component of a rare caterpillar fungus, demonstrated protective effects in NDEA-induced HCC via downregulation of pro-inflammatory cytokines IL-6, IL−1β, IL-2, TNF-α and modulation of the PI3K-Akt-mTOR pathway ( Keshari et al, 2017 ; Zeng et al, 2017 ). In an AOM/DSS model of colon carcinogenesis, an anti-cancer compound celastrol, reduces COX-2, TNF-α, IL-6, IL−1β and iNOS ( Barker et al, 2018 ).…”
Section: Mechanisms Of Pro-tumorigenic Activity By Carcinogensmentioning
confidence: 99%
“…It has been confirmed that cordycepin has anticancer effects on various kinds of cancer cells, including lung cancer (14), colorectal cancer (15), liver cancer (HCC) (16), breast cancer (17), brain cancer (18), and bladder cancer (19) cells in vitro. Accumulating evidence implies that cordycepin could promote the phosphorylation of PI3K/Akt and DNA damage, which induce the emergence of reactive oxygen species (ROS) and result in cancer cells apoptosis (20,21). Additionally, it has also been demonstrated that cordycepin has considerable anticancer effects on drug-resistance NSCLC both in vitro and in vivo, and its anticancer effect is comparable to currently available targeted therapeutic drugs (22).…”
Section: Introductionmentioning
confidence: 99%
“…Other bioactive components, cordycepin, cordycepic acid, myriocin and beauvericin in I. cicadae, are reported to inhibit the growth of carcinoma cells [38]. Cordycepin resists the growth of hepatocarcinoma via PI3K/Akt/mTOR and Nrf2/HO-1/NF-κB pathway [39]. In this study, feeding broiler chickens with culture media from solid-state fermented I. cicadae in diets increased serum IL-1β levels during phase I (d 1 to 21) and phase II (d 22 to 42), suggesting it promoted cellular immune responses.…”
mentioning
confidence: 99%